FDA approves novel treatment to target abnormality in sickle cell disease
- Details
- Category: FDA

"Today's approval provides additional hope to the 100,000 people in the U.S., and the more than 20 million globally, who live with this debilitating blood disorder," said Acting FDA Commissioner Adm. Brett P. Giroir, M.D.
FDA approves first treatment for inherited rare disease
- Details
- Category: FDA

FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
- Details
- Category: FDA

FDA approves first therapy to treat patients with rare blood disorder
- Details
- Category: FDA

Digital submission of adverse event reports for investigational new drug applications
- Details
- Category: FDA

First vaccine to protect against Ebola
- Details
- Category: EMA

FDA approves new treatment for patients with migraine
- Details
- Category: FDA

More Pharma News ...
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
- FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
- FDA approves first oral GLP-1 treatment for type 2 diabetes
- FDA takes first action under new international collaboration with Australia and Canada
- FDA approves first treatment for patients with rare type of lung disease
- EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US